This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barsov, E. V. Articles by Hughes, S. H. Search for Related Content PubMed PubMed Citation Articles by Barsov, E. V. Articles by Hughes, S. H.

 Previous Article  |  Next Article 

J. Virol., Jul 1996, 4484-4494, Vol 70, No. 7
Copyright © 1996, American Society for Microbiology

Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions

EV Barsov, WE Huber, J Marcotrigiano, PK Clark, AD Clark, E Arnold and SH Hughes
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA.

We have characterized a murine monoclonal antibody (MAb 35), which was raised against human immunodeficiency virus type 1 (HIV-1) integration protein (IN), and the corresponding Fab 35. Although MAb 35 does not inhibit HIV-1 IN, Fab 35 does. MAb 35 (and Fab 35) binds to an epitope in the C-terminal region of HIV-1 IN. Fab 35 inhibits 3'-end processing, strand transfer, and disintegration; however, DNA binding is not affected. The available data suggest that Fab 35 inhibits enzymatic activities of IN by interfering with the ability of IN to form multimers that are enzymatically active. This implies that the C- terminal region of HIV-1 IN participates in interactions that are essential for the multimerization of IN. Titration of the various IN- mediated enzymatic activities suggests that different degrees of multimerization are required for different activities of HIV-1 IN.

This article has been cited by other articles:

• Oz Gleenberg, I., Avidan, O., Goldgur, Y., Herschhorn, A., Hizi, A. (2005). Peptides Derived from the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 as Novel Inhibitors of the Viral Integrase. J. Biol. Chem. 280: 21987-21996 [Abstract] [Full Text]  
• Berger, N., Heller, A. E., Störmann, K. D., Pfaff, E. (2001). Characterization of chimeric enzymes between caprine arthritis-encephalitis virus, maedi-visna virus and human immunodeficiency virus type 1 integrases expressed in Escherichia coli. J. Gen. Virol. 82: 139-148 [Abstract] [Full Text]  
• Legastelois, I., Desgranges, C. (2000). Design and Intracellular Activity of a Human Single-Chain Antibody to Human Immunodeficiency Virus Type 1 Conserved gp41 Epitope. J. Virol. 74: 5712-5715 [Abstract] [Full Text]  
• Petit, C., Schwartz, O., Mammano, F. (1999). Oligomerization within Virions and Subcellular Localization of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 73: 5079-5088 [Abstract] [Full Text]  
• Ishikawa, T., Okui, N., Kobayashi, N., Sakuma, R., Kitamura, T., Kitamura, Y. (1999). Monoclonal Antibodies against the Minimal DNA-Binding Domain in the Carboxyl-Terminal Region of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 73: 4475-4480 [Abstract] [Full Text]  
• Katzman, M., Sudol, M. (1998). Mapping Viral DNA Specificity to the Central Region of Integrase by Using Functional Human Immunodeficiency Virus Type 1/Visna Virus Chimeric Proteins. J. Virol. 72: 1744-1753 [Abstract] [Full Text]  
• Acel, A., Udashkin, B. E., Wainberg, M. A., Faust, E. A. (1998). Efficient Gap Repair Catalyzed In Vitro by an Intrinsic DNA Polymerase Activity of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 72: 2062-2071 [Abstract] [Full Text]